Three years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102); preliminary analysis

Date

2009-10

Authors

Marcellin, Patrick
Buti, Maria
Krastev, Zahary
Germanidis, George
Kaita, Kelly D.
Kotzev, Iskren
Buggisch, Peter
Weilert, Frank
Trinh, Huy N.
Heathcote, E. Jenny

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Abstract

Amer Assoc Study Liver Dis

Description

Bu çalışma, 30 Ekim-03 Kasım 2009 tarihleri arasında Boston[Massachusetts]’da düzenlenen 60. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.

Keywords

Gastroenterology & hepatology

Citation

Marcellin, P. vd. (2009) "Three years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102); preliminary analysis". Hepatology, 50(4), 532A-533A.

Collections